Founded in 2019 by Victor Velculescu, a leader in cancer genomics, Delfi Diagnostics is committed to developing high-performing, affordable blood tests for early detection of cancer across multiple tumor types. Leveraging recent advances in cancer biology and machine learning, DELFI's technology can achieve high performance from low-cost, widely available sequencing technology. Delfi Diagnostics has raised over $100 million in seed and series A funding.
What is a Data Scientist at Delfi Diagnostics? The role of a Data Scientist at Delfi Diagnostics is pivotal in leveraging data to drive innovation in healthcare diagnostics. As a Data Scientist, you will be at the forefront of developing algorithms and analytical models that enhance the accuracy and efficiency...
